Mirae Asset Global Investments Co. Ltd. has a $4.72 million equity position in Myriad Genetics, Inc. (NASDAQ:MYGN)
Mirae Asset Global Investments Co. Ltd. cut its holdings in…
Mirae Asset Global Investments Co. Ltd. cut its holdings in…
Tara Rothenhoefer started taking tyrzepatide as part of a weight…
Tara Rothenhoefer started taking tyrzepatide as part of a weight…
The researchers have important implications for the ongoing fight against…